MacroGenics Change in Accounts Payable 2012-2025 | MGNX

MacroGenics change in accounts payable from 2012 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

MacroGenics Change in Accounts Payable 2012-2025 | MGNX

MacroGenics change in accounts payable from 2012 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.6B
Boston Scientific (BSX)$152.2B
Stryker (SYK)$144B
EssilorLuxottica (ESLOY)$135.6B
Medtronic (MDT)$118.9B
Lonza Group Ag (LZAGY)$46.7B
Haleon (HLN)$42.5B
ResMed (RMD)$41.6B
GE HealthCare Technologies (GEHC)$33.3B
Agilent Technologies (A)$32.4B
Terumo (TRUMY)$27.5B
Koninklijke Philips (PHG)$25.7B
Insulet (PODD)$21.5B
Zimmer Biomet Holdings (ZBH)$19.8B
Smith & Nephew SNATS (SNN)$15.7B
Baxter (BAX)$12B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$3.8B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Prestige Consumer Healthcare (PBH)$3.1B
Perrigo (PRGO)$3B
ICU Medical (ICUI)$2.7B
Haemonetics (HAE)$2.5B
LeMaitre Vascular (LMAT)$2.1B
Curaleaf Holdings (CURLF)$1.9B
Green Thumb Industries (GTBIF)$1.8B
AtriCure (ATRC)$1.8B